NeuroRx
  • Home
  • About Us
  • Covid-19
  • NRX-100/101
  • News
  • Contact
  • Home
  • News
  • Clinical Trials

Tag: Clinical Trials

Broadcasts

Prof Jonathan Javitt joins i24NEWS – FDA Grants Continuation of COVID-19 Trial

https://www.youtube.com/watch?v=ogvdYGj5hQQ&feature=share&fbclid=IwAR33RM6pud-jcg0K5WGpDzFq27PdTcu8rYKZ_VDQagylTubUFm7aIo1UWm4
Read more
Press releases

NeuroRx and Relief Therapeutics Announce Data Monitoring Committee Determination to Continue Phase 2/3 Trial of RLF-100 for Critical COVID-19

With resurgent COVID-19, enrollment has accelerated in Miami, Houston, and Irvine.

Read more
News

Is There Another Coronavirus Treatment? What To Know About The Fast-Tracked Drug Aviptadil

A drug that mimics a peptide produced by the bowel has been fast-tracked by the Food and Drug Administration to treat COVID-19 lung inflammation, NeuroRx Inc. announced Wednesday. The drug protects cells believed to act as a gateway for the coronavirus to attack the lungs.

Read more
Press releases

NeuroRx and Relief Therapeutics Announce Fast Track Designation Granted by the FDA to RLF-100 (Aviptadil) for the Treatment of Respiratory Distress in COVID-19

Fast Track Designation of RLF-100 for the treatment of Acute Lung Injury/Acute Respiratory Distress Syndrome associated with COVID-19 underscores the urgent need for new treatment options for these patients.

Read more
Broadcasts

Focusing on You: UM Tests Drug to Lessen Severity of COVID-19

University of Miami Health System

Read more
Press releases

Relief Therapeutics and NeuroRx Expand Clinical Trial Evaluating RLF-100 in Critically Ill COVID-19 Patients with Respiratory Failure to Houston Methodist Hospital

Clinical trial expanded to patients treated with both noninvasive and mechanical ventilation in Critical COVID-19.

Read more
Press releases

Relief Therapeutics and NeuroRx Expand Clinical Trial of RLF-100 to All Patients with Critical COVID-19 and Respiratory Failure

Clinical trial expanded to patients treated with both noninvasive and mechanical ventilation in critical COVID-19.

Read more
Press releases

Relief Therapeutics and NeuroRx Announce Enrollment of First Patients with RLF-100 in Phase 2b/3 Clinical Trial in Patients with COVID-19 Associated Acute Respiratory Distress

First participants treated at the University of Miami Miller School of Medicine with intravenous RLF-100.

Read more
Broadcasts

UM Hospital Testing New Treatment For Patients Suffering The Worst Of COVID-19

https://www.youtube.com/watch?v=ztSFZlavXU0&feature=youtu.be
Read more
Broadcasts

FDA advances Covid-19 therapy-Prof. Jonathan Javitt

https://www.youtube.com/watch?v=lgmpS2N8124
Read more

Posts navigation

Older posts

Categories

  • Broadcasts
  • News
  • Press releases

Tags

ARDS Aviptadil Big Rock Partners Bipolar Depression Clinical Trials Covid-19 Emergency Use Expanded Access Fast Track FDA Houston I-Spy i24 News NASDAQ NRX-100/101 NRXP Orphan Drug Designation Respiratory Failure RLF-100 VIP Zysami

Developing innovative therapies for high-mortality unmet needs.

Company Info

  • About Us
  • RLF-100
  • NRX 100/101

Learn More

  • USA-Licensed Physicians
  • Investors
© 2020 NeuroRx, Inc.